Systemic Lupus Erythematosus Onset Seven Years After Initiation of Highly Active Antiretroviral Therapy in a Patient With Human Immunodeficiency Virus: Literature Review and Update on Disease Mechanism of This Unusual Presentation.

J Clin Rheumatol

Division of Rheumatology, Department of Medicine, NYU Langone Medical Center, and NYU School of Medicine, New York, NY Internal Medicine Residency Program, NYU School of Medicine, New York, NY NYU School of Medicine, New York, NY Division of Rheumatology, Department of Medicine, NYU Langone Medical Center, and NYU School of Medicine, New York, NY.

Published: September 2016

Download full-text PDF

Source
http://dx.doi.org/10.1097/RHU.0000000000000426DOI Listing

Publication Analysis

Top Keywords

systemic lupus
4
lupus erythematosus
4
erythematosus onset
4
onset years
4
years initiation
4
initiation highly
4
highly active
4
active antiretroviral
4
antiretroviral therapy
4
therapy patient
4

Similar Publications

Objective: This study investigates the barriers and facilitators to sustaining a decision aid (DA) tool for patients with systemic lupus erythematosus (SLE) in routine rheumatology outpatient care across the U.S. The DA was initially developed for assisting Patients with SLE in making informed medication choices by providing personalized information on their treatment process.

View Article and Find Full Text PDF

Introduction: Bruton's tyrosine kinase (BTK) is a cytoplasmic signaling protein expressed across a variety of immune cells, terminally differentiated plasma cells, and natural killer cells. Due to the signal potential and targetable nature of BTK, the use of BTK inhibitors (BTKis) has been proposed for the management of several diseases. Currently, the use of BTKis is under investigations for several dermatological conditions such as pemphigus, systemic lupus erythematosus, hidradenitis suppurativa, atopic dermatitis, and chronic spontaneous urticaria (CSU).

View Article and Find Full Text PDF

Big Heart, Small Shoes: Heart Failure in Systemic Lupus Erythematosus, More Than Lupus Cardiac Involvement.

CJC Open

January 2025

Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College; National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology; State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital; Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing, China.

View Article and Find Full Text PDF

Ten tips in lupus nephritis management.

Clin Kidney J

January 2025

Division of Nephrology, School of Clinical Medicine, Queen Mary Hospital, University of Hong Kong, Hong Kong SAR.

Lupus nephritis is an important cause of severe glomerulonephritis, and a leading cause of kidney failure in young adults. While the disease can lead to rapid destruction of nephrons if untreated, there are effective therapies to reverse the severe acute kidney injury and prevent the lifetime risk of kidney failure. Early diagnosis and timely intervention are therefore of critical importance.

View Article and Find Full Text PDF

Several neurological conditions, including transient global amnesia (TGA), may present an isolated sudden-onset temporary amnestic symptom. TGA is a benign, self-remitting neurological condition associated with hippocampal dysfunction. Meanwhile, certain other neurological conditions, such as cerebral ischemic stroke and hippocampal epilepsy, require appropriate therapeutic interventions.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!